Lilly Now Sees Obesity Pill Approval as Early as Second Quarter

Eli Lilly & Co. said Monday it expects its highly anticipated weight-loss pill to receive US regulatory approval as early as the second quarter of 2026, slightly later than it signaled earlier.

The pill is “on track” for the second-quarter timeline, Lilly Chief Financial Officer Lucas Montarce said in an interview with Bloomberg TV on the sidelines of the JPMorgan Healthcare Conference in San Francisco. In November, Chief Executive Officer Dave Ricks said the pill, orforglipron, could receive regulatory clearance by March.

Drugmakers believe weight-loss pills could expand the market for popular GLP-1 medicines, which ...